Cannabis-based Medicine Cannabis-based Medicine

In-vivo models

Cannabis-based Medicine

Cannabis-based drug development

Pharmaseed guides you through your cannabis-based drug development. Our long experience, enable us to understand the specificity of your technology, find the most appropriate animal models that will translate into clinical indication.

  • We do animal studies for a variety of indications: post-operative pain, epilepsy, multiple sclerosis, glaucoma, anxiety-PTSD, Parkinson’s disease,  rheumatoid arthritis, cachexia, nausea-vomiting cancer, post-operative pain…
  • For these clinical indications, we can test the mode of administration, the dose, frequency, duration and timing.
  • We also perform pharmacology and formulation studies.


Cannabis Brochure - Pharmaseed Ltd.


Monetizing medical cannabis

To ensure a successful cannabis-derived drug development, IP rights counseling, regulatory knowledge and pre-clinical expertise are indispensable. Discover how Dr Eyal Bressler and co and Pharmaseed Ltd can help you monetize your drug development program.


Monetizing medical cannabis from Pharmaseed Ltd

For more information on how we can help you
move your drug or device along the development pathway.
Contact Us